UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1199-1212

2016

Volltextzugriff (PDF)

Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2020-03, Vol.14 (3), p.316-322

2020

Volltextzugriff (PDF)

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2003-05, Vol.17 (10), p.1273-1281

2003

Volltextzugriff (PDF)

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Gut, 2005-02, Vol.54 (2), p.228-236

2005

Volltextzugriff (PDF)

Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?

Gut, 2006-03, Vol.55 (3), p.342-347

2006

Volltextzugriff (PDF)

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Gut, 2005-07, Vol.54 (7), p.960-965

2005

Volltextzugriff (PDF)

Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel

Inflammatory bowel diseases, 2004-07, Vol.10 (4), p.373-382

2004

Volltextzugriff (PDF)

Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (12), p.1286-1295

2010

Volltextzugriff (PDF)

Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study

Journal of Crohn's and colitis, 2011-06, Vol.5 (3), p.203-210

2011

Volltextzugriff (PDF)

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.31-37

2016

Volltextzugriff (PDF)

Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation

Alimentary pharmacology & therapeutics, 2004-05, Vol.19 (10), p.1073-1078

2004

Volltextzugriff (PDF)

Health care and cost of medication for inflammatory bowel disease in the Rhein‐Main region, Germany: A multicenter, prospective, internet‐based study

Inflammatory bowel diseases, 2008-01, Vol.14 (1), p.53-60

2008

Volltextzugriff (PDF)

Bone Loss in Patients with Inflammatory Bowel Disease Is Less Than Expected: A Follow-up Study

Scandinavian journal of gastroenterology, 1999, Vol.34 (7), p.696-702

1999

Volltextzugriff (PDF)

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis

Gastroenterology (New York, N.Y. 1943), 2018-12, Vol.155 (6), p.1795-1804.e3

2018

Volltextzugriff (PDF)

Shingles following infliximab infusion

Annals of the rheumatic diseases, 2002-07, Vol.61 (7), p.661-661

2002

Volltextzugriff (PDF)

A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding

Zeitschrift für Gastroenterologie, 2004-08, Vol.42 (8), p.663-667

2004

Volltextzugriff (PDF)

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease

The New England journal of medicine, 2024-07, Vol.391 (3), p.213-223

2024

Volltextzugriff (PDF)

White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study

Clinical gastroenterology and hepatology, 2015-10, Vol.13 (10), p.1776-1781.e1

2015

Volltextzugriff (PDF)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.61-68

2016

Volltextzugriff (PDF)

Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease

Inflammatory bowel diseases, 1998-11, Vol.4 (4), p.268-275

1998

Volltextzugriff (PDF)

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

The American journal of gastroenterology, 2010-07, Vol.105 (7), p.1574-1582

2010

Volltextzugriff (PDF)

Impact of pain on health-related quality of life in patients with inflammatory bowel disease

World journal of gastroenterology : WJG, 2010-07, Vol.16 (25), p.3168-3177

2010

Volltextzugriff (PDF)

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Clinical gastroenterology and hepatology, 2010-07, Vol.8 (7), p.600-609

2010

Volltextzugriff (PDF)

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial

Journal of Crohn's and colitis, 2018-05, Vol.12 (6), p.687-694

2018

Volltextzugriff (PDF)

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

Journal of Crohn's and colitis, 2014-09, Vol.8 (9), p.970-980

2014

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(58)

Sprache

Englisch
(56)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel

Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis

Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation

Health care and cost of medication for inflammatory bowel disease in the Rhein‐Main region, Germany: A multicenter, prospective, internet‐based study

Bone Loss in Patients with Inflammatory Bowel Disease Is Less Than Expected: A Follow-up Study

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis

Shingles following infliximab infusion

A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease

White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

Impact of pain on health-related quality of life in patients with inflammatory bowel disease

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

Aktive Filter

Suchergebnisse filtern